Katalin Rázsó

Complement activation in thrombotic thrombocytopenic purpura

Marienn Réti, Péter Farkas, Dorottya Csuka et al. · Journal of Thrombosis and Haemostasis · 2012 · 135 citations · Full text

Medicine, Hematology, Immunology +14

Concentration and Subclass Distribution of Anti-ADAMTS13 IgG Autoantibodies in Different Stages of Acquired Idiopathic Thrombotic Thrombocytopenic Purpura

György Sinkovits, Ágnes Szilágyi, Péter Farkas et al. · Frontiers in Immunology · 2018 · 34 citations · Full text

Life Sciences, Immunology, Pathology +16

Stem Cell Therapy: A Promising and Prospective Approach in the Treatment of Patients With Severe Buerger’s Disease

Z Boda, Miklós Udvardy, Katalin Rázsó et al. · Clinical and Applied Thrombosis/Hemostasis · 2008 · 26 citations · Full text

Medicine, Orthopaedic Surgery, Surgery +13

Clinical and laboratory characteristics of antithrombin deficiencies: A large cohort study from a single diagnostic center

Réka Gindele, Anna Selmeczi, Zsolt Oláh et al. · Thrombosis Research · 2017 · 26 citations · Full text

Medicine, Hematology, Internal Medicine +15

The role of human leukocyte antigen DRB1-DQB1 haplotypes in the susceptibility to acquired idiopathic thrombotic thrombocytopenic purpura

György Sinkovits, Ágnes Szilágyi, Péter Farkas et al. · Human Immunology · 2016 · 21 citations

Life Sciences, Genetics, Immunology +12